Longitudinal kinetics of human epididymis protein 4 in recurrent advanced ovarian carcinoma treated with platinum-based chemotherapy: mathematical modeling and prognostic implications [0.03%]
人类附睾蛋白4在复发性卵巢癌中动力学特征的纵向研究及其预后意义铂类化疗治疗
Petra Nardelli,Katharina Leitner,Aurore Carrot et al.
Petra Nardelli et al.
Objective: Evidence on the clinical utility of baseline human epididymis protein 4 levels and their kinetics in recurrent ovarian cancer remains limited. This study evaluated longitudinal human epididymis protein 4 dynami...
Is conization with lymph node dissection safe for International Federation of Gynecology and Obstetrics 2018 stage IB1 cervical cancer measuring 1 to 2 cm? [0.03%]
国际妇产科联盟（FIGO）2018年IB1期宫颈癌（肿瘤直径1～2cm）行锥切联合淋巴结清扫术是否安全？
Houssein El Hajj,Sébastien Gouy,Elaine Limkin et al.
Houssein El Hajj et al.
Best original research presented at the 27th European Congress on Gynaecological Oncology: best of ESGO 2026 [0.03%]
第27届欧洲妇科肿瘤大会最佳原创研究：ESGO 2026年会亮点
Houssein El Hajj,Alexander Shushkevich,Joanna Kacperczyk-Bartnik et al.
Houssein El Hajj et al.
The Best of the European Society of Gynaecological Oncology 2026 review highlights a selection of the best original research presented at the 27th Congress of the European Society of Gynaecological Oncology, held February 26 to 28, 2026, in...
Correspondence on "Reconsidering the control arm in hyperthermic intra-peritoneal chemotherapy trials for epithelial ovarian cancer: are we comparing equivalent chemotherapy exposure?" by Poonyakanok et al [0.03%]
Pooneyakanok等关于“重新考虑腹腔内热灌注化疗试验中的对照臂：我们比较的化疗暴露相当吗？”一文的通信答复
Ji Hyun Kim,Michela Quaranta,Myong Cheol Lim
Ji Hyun Kim
Efficacy and safety of immune checkpoint inhibitor rechallenge in cervical and endometrial cancer: a multi-center retrospective study (RICE study) [0.03%]
宫颈癌和子宫内膜癌免疫检查点抑制剂再挑战疗效与安全性研究（RICE 研究）
Rayan Kabirian,Mathilde de Saint Ghislain,Olivia Le Saux et al.
Rayan Kabirian et al.
Objective: Immune checkpoint inhibitors have significantly improved the outcome of patients with cervical and endometrial cancers but the benefit of immune checkpoint inhibitor rechallenge is unknown. We aimed to evaluate...
Mortality trends and disparities in ovarian cancer among women aged 45 years and older in the United States, 1999-2020: a CDC WONDER analysis [0.03%]
美国45岁及以上女性卵巢癌死亡率和差异趋势（1999-2020年）：一项CDC WONDER分析结果
Wenxiang Wang,Zhanghuan Li,Mengyuan Chang et al.
Wenxiang Wang et al.
Objective: Ovarian cancer remains a major cause of gynecologic cancer death in the United States, particularly among women aged 45 years and older. However, long-term national data on mortality trends and sub-group dispar...
Andrej Cokan,Tibor A Zwimpfer,David Viveros-Carreño et al.
Andrej Cokan et al.
Fertility-sparing treatment is an established option for reproductive-age women with early-stage endometrioid endometrial cancer or atypical endometrial hyperplasia. Despite high initial response rates with progestin-based therapy, predicti...
Image-guided brachytherapy for locally advanced cervical cancer: clinical outcomes and fistula risk in stage IVA disease [0.03%]
图像引导的宫颈局部晚期癌后装治疗的效果及Ⅳ期疾病的瘘管风险
Yosef Landman,Cecilia De Sousa Smith,Suqi Ke et al.
Yosef Landman et al.
Objective: To report outcomes for patients with locally advanced cervical cancer, with a focus on stage IVA disease, and to explore factors associated with fistula formation. ...
Does the prophylactic use of compression garments reduce the risk of lower limb lymphedema after pelvic and/or inguinal lymphadenectomy for gynecological cancer? A systematic review [0.03%]
预防性使用压力服装可降低妇科肿瘤盆腔和/或腹股沟淋巴结清扫术后下肢淋巴水肿的风险吗？系统评价
Stefano Gentileschi,Giorgia Garganese,Simona Maria Fragomeni et al.
Stefano Gentileschi et al.
Objective: Our goal was to assess whether prophylactic compression garments reduce lower-limb lymphedema after pelvic/inguinal lymphadenectomy for gynecologic malignancies. ...